Some people just run lower on vitamin D. Genes are part of why.
Two colleagues, same city, same office, same cloudy winter. One gets a blood test and lands comfortably mid-range for vitamin D; the other comes back low, again, despite the same habits. Sun exposure, skin tone, diet, and body weight explain most of the gap between people, but there is also a quieter contributor: the genes that move vitamin D around the body.
Where genes touch the pipeline
Vitamin D goes through a small pipeline before your body can use it: made in the skin (or eaten), carried in the blood by a transport protein, and activated by liver and kidney enzymes. Two well-replicated gene regions sit right on that pipeline.
The first is GC, the gene for the vitamin D binding protein, the delivery van for vitamin D in your bloodstream. Several markers there (rs2282679, rs7041, rs4588, close neighbors that mostly travel together and should be read as one signal) are associated in large population studies with measurably lower or higher circulating vitamin D, a small shift per copy. The second is CYP2R1 (marker rs10741657), the liver enzyme that performs the first activation step; its variants nudge measured levels the same modest way.
Stack a few unlucky copies and your baseline sits noticeably lower than a neighbor with the lucky set, all habits held equal. This is one of the better-replicated nutrition findings in the consumer genetics space, with strong evidence across multiple large studies.
What this changes in practice
Less than the supplement aisle wants you to think, and more than nothing.
It does not mean your genotype sets your dose. Vitamin D need depends mostly on sun, season, skin, and weight, and the blood test is cheap and definitive; no genotype outranks an actual measurement. If you are deciding anything that matters, measure.
What the genotype is genuinely good for is prior probability. A low-leaning set of markers is a reason to actually get that winter test instead of assuming you are fine, and a reason not to be surprised when your level drifts down faster than other people's after summer ends. A high-leaning set is a reason to be a little more skeptical that vitamin D explains whatever symptom the internet is currently pinning on it.
One more honest note: genetically lower vitamin D has not translated into a clear green light for high-dose supplementation in trials, so the boring advice stands: sensible sun, food sources, a standard supplement in dark months if you and your doctor decide it fits, and retest rather than escalate.
Your Helisoma report reads all the GC and CYP2R1 markers together, tells you which way your baseline leans and how strong the evidence is, and links every study. Connect it to your AI assistant and ask when in the year a test makes sense for your profile.
Sources
- GC and CYP2R1 variants and circulating vitamin D in genome-wide studies. PubMed 20418485
- Large-scale analysis of vitamin D level determinants. PubMed 29325163
- GC variants and measured vitamin D. PubMed 36811574